News Johnson & Johnson’s Positive Nipocalimab Results Johnson & Johnson has reported positive results for its drug nipocalimab in a Phase 2 clinical trial. The drug has been shown to ... By Artur FernandoJune 29, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024